BY HIS OWN DEVICE

A BIOTECH LAB RACES TO PERFECT A NEW TREATMENT FOR CANCER JUST IN TIME TO SAVE ITS DYING CEO

It's not that the lab folks at tiny CellPro, Inc. are uninterested in saving lives. It's just that like most biotech researchers, they prefer to toil far away from the gritty reality of illness and human suffering. So when the CEO of their Bothell, Wash., company announced a year ago that he had developed a deadly lymphatic cancer and that his slim chance for survival might rest on their lab results, it was more than they'd bargained for. They already knew their company was fighting for survival, locked in a legal battle over patents with a competitor. Now they were also...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!